Journal: BMC Pharmacology & Toxicology

Article Title: Rotigotine safety in real-world settings: a pharmacovigilance study using FAERS data

doi: 10.1186/s40360-025-00911-5

Figure Lengend Snippet: The flow diagram of selecting Rotigotine-related AEs from FAERS database

Article Snippet: Concurrently, in a German clinical trial assessing the efficacy and tolerability of rotigotine for treating RLS led by Karin Stiasny-Kolster et al., a total of 84 skin reactions were documented among 66 (9.6%) of the patients.

Techniques:

Journal: BMC Pharmacology & Toxicology

Article Title: Rotigotine safety in real-world settings: a pharmacovigilance study using FAERS data

doi: 10.1186/s40360-025-00911-5

Figure Lengend Snippet: Clinical characteristics of reports with rotigotine from the FAERS database

Article Snippet: Concurrently, in a German clinical trial assessing the efficacy and tolerability of rotigotine for treating RLS led by Karin Stiasny-Kolster et al., a total of 84 skin reactions were documented among 66 (9.6%) of the patients.

Techniques:

Journal: BMC Pharmacology & Toxicology

Article Title: Rotigotine safety in real-world settings: a pharmacovigilance study using FAERS data

doi: 10.1186/s40360-025-00911-5

Figure Lengend Snippet: Time to onset of Rotigotine-associated adverse events and Weibull distribution analysis

Article Snippet: Concurrently, in a German clinical trial assessing the efficacy and tolerability of rotigotine for treating RLS led by Karin Stiasny-Kolster et al., a total of 84 skin reactions were documented among 66 (9.6%) of the patients.

Techniques:

Journal: BMC Pharmacology & Toxicology

Article Title: Rotigotine safety in real-world settings: a pharmacovigilance study using FAERS data

doi: 10.1186/s40360-025-00911-5

Figure Lengend Snippet: The signal strength of AEs related to rotigotine at the SOC level in the FAERS database was detected by four algorithms

Article Snippet: Concurrently, in a German clinical trial assessing the efficacy and tolerability of rotigotine for treating RLS led by Karin Stiasny-Kolster et al., a total of 84 skin reactions were documented among 66 (9.6%) of the patients.

Techniques:

Journal: BMC Pharmacology & Toxicology

Article Title: Rotigotine safety in real-world settings: a pharmacovigilance study using FAERS data

doi: 10.1186/s40360-025-00911-5

Figure Lengend Snippet: Signal Strength of top20 AEs of Rotigotine at the PT Level in FAERS Database

Article Snippet: Concurrently, in a German clinical trial assessing the efficacy and tolerability of rotigotine for treating RLS led by Karin Stiasny-Kolster et al., a total of 84 skin reactions were documented among 66 (9.6%) of the patients.

Techniques:

Journal: BMC Pharmacology & Toxicology

Article Title: Rotigotine safety in real-world settings: a pharmacovigilance study using FAERS data

doi: 10.1186/s40360-025-00911-5

Figure Lengend Snippet: The top 30 most frequent adverse events for rotigotine excluding common medication co-usage at the PT level from FAERS data

Article Snippet: Concurrently, in a German clinical trial assessing the efficacy and tolerability of rotigotine for treating RLS led by Karin Stiasny-Kolster et al., a total of 84 skin reactions were documented among 66 (9.6%) of the patients.

Techniques:

Journal: BMC Pharmacology & Toxicology

Article Title: Rotigotine safety in real-world settings: a pharmacovigilance study using FAERS data

doi: 10.1186/s40360-025-00911-5

Figure Lengend Snippet: The top 30 signal strength of adverse events of rotigotine ranked by the number of case reports at the PTs level in FAERS database

Article Snippet: Concurrently, in a German clinical trial assessing the efficacy and tolerability of rotigotine for treating RLS led by Karin Stiasny-Kolster et al., a total of 84 skin reactions were documented among 66 (9.6%) of the patients.

Techniques: